Anixa Biosciences: Hard To Justify The Market's Optimism With An Upcoming Phase 1 Readout [Seeking Alpha]
Anixa Biosciences, Inc. (ANIX)
Last anixa biosciences, inc. earnings: 3/9 05:10 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
ANIX will present a more complete phase 1 data readout at SABCS in December, and the market appears to be anticipating this. However, the likelihood of a phase 1 trial making a huge impact is low, and I think the market will come away disappointed. Coupling that with a small cash position, ANIX does not appear to justify the current market cap, which sits at a high multiple relative to their current assets. J Studios/DigitalVision via Getty Images Topline Summary and Update It's been a while since I followed up on Anixa Biosciences ( ANIX ), noting that I felt their December 2024 price, even though it was quite low, did not appear to represent This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from
Show less
Read more
Impact Snapshot
Event Time:
ANIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIX alerts
High impacting Anixa Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
ANIX
News
- Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic [Yahoo! Finance]Yahoo! Finance
- Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland ClinicPR Newswire
- Anixa Biosciences (NASDAQ:ANIX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.MarketBeat
- Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants [Yahoo! Finance]Yahoo! Finance
- Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of ParticipantsPR Newswire
ANIX
Earnings
- 1/12/26 - Miss
ANIX
Sec Filings
- 1/12/26 - Form S-8
- 1/12/26 - Form 10-K
- 1/6/26 - Form SCHEDULE
- ANIX's page on the SEC website